These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 345998)

  • 1. [Comparative studies of the response of normolipemic and dyslipemic aged subjects to 2 forms of delayed-action nicotinic acid polyesters. Pentaerythrotol tetranicotinate and inositol hexanicotinate. Results of a controlled cross-over trial].
    Ziliotto GR; Lamberti G; Wagner A; Cima L; Genco G
    Arch Sci Med (Torino); 1977; 134(4):359-94. PubMed ID: 345998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
    G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of hexanicotinate of meso-inositol in patients with primary hyperlipidemia (author's transl)].
    Agusti R; Jordán C; Aste H; Tapia F
    Rev Invest Clin; 1978; 30(4):327-35. PubMed ID: 362498
    [No Abstract]   [Full Text] [Related]  

  • 5. [New drug combination for medical management of hyperlipemia: clinical study].
    Fischer M; Falkensammer C
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):585-9. PubMed ID: 340391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inositol hexanicotinate and its cholesteropenic effect].
    Crotte Zamora A; Romo López O
    Prensa Med Mex; 1974; 39(5-6):287-93. PubMed ID: 4612506
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study with a new antihyperlipemic combination].
    Pistautz H
    Arzneimittelforschung; 1977; 27(1):152-6. PubMed ID: 576816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arteriosclerosis--nicotinic acid therapy. 7. Effect of nicotinic acid on lipoproteins].
    Carlson LA
    Lakartidningen; 1971 Apr; 68(15):1763-4. PubMed ID: 5577249
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of various types of hyperlipoproteinaemia with a combination of Mg-chlorophenoxy-isobutyrate and mesoinositol-hexanicotinate (author's transl)].
    Bolzano K; Krempler F; Haslauer F
    Arzneimittelforschung; 1979; 29(10):1621-4. PubMed ID: 583231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)].
    Schimert G
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):389-92. PubMed ID: 4208098
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of ischemic heart disease with a hypolipoproteinemic drug pericit].
    Britov AN; Shmushkovich BI; Karmanskiĭ IM
    Kardiologiia; 1977 Jun; 17(6):87-91. PubMed ID: 197290
    [No Abstract]   [Full Text] [Related]  

  • 12. The anti-platelet effect of niceritrol in patients with arteriosclerosis and the relationship of the lipid-lowering effect to the anti-platelet effect.
    Nagakawa Y; Orimo H; Harasawa M
    Thromb Res; 1985 Nov; 40(4):543-53. PubMed ID: 4082125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
    Turazza G; Spreafico PL; Frandoli G
    Arzneimittelforschung; 1973 May; 23(5):654-7. PubMed ID: 4575777
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress on a new form of treatment of lipoarteriosis].
    Vargas LE; Velasco JR
    Rev Esp Cardiol; 1972; 25(3):239-46. PubMed ID: 5069029
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of different dose regimens of niceritrol of serum lipid concentrations in man.
    Rössner S; Olsson AG; Orö L
    Acta Med Scand; 1976; 200(4):269-71. PubMed ID: 983794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs.
    Lundholm L; Jacobsson L; Brattsand R; Magnusson O
    Atherosclerosis; 1978 Feb; 29(2):217-39. PubMed ID: 646851
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased compliance of niceritrol treatment by addition of aspirin: relationship between changes in prostaglandins and skin flushing.
    Nozaki S; Kihara S; Kubo M; Kameda K; Matsuzawa Y; Tarui S
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):643-7. PubMed ID: 3481359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1975; 22(1):91-101. PubMed ID: 1098680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 20. The antilipemic effectiveness of pentaerythritol tetranicotinate on hyperlipidemic patients with or without diabetes mellitus--a double-blind, randomized and two-period change-over experiment.
    Ho LT; Chern JC; Hsu SC; Chen RL; Kwok CF; Wu MS; Chen JJ; Jap TS
    Proc Natl Sci Counc Repub China B; 1985 Jan; 9(1):20-9. PubMed ID: 3916369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.